A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Clinical trial NCT04868162 · RECRUITING
Trial details
- NCT number
- NCT04868162
- Sponsor
- Shanghai Miracogen Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-23
- Primary completion
- 2026-06-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.